Spero therapeutics to present at upcoming investor conferences

Cambridge, mass., feb. 28, 2023 (globe newswire) -- spero therapeutics, inc. (nasdaq: spro) (spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (mdr) bacterial infections, today announced that ankit mahadevia, m.d., president and chief executive officer of spero therapeutics, will present and be available for one-on-one meetings at the cowen 43rd annual healthcare conference, which is taking place march 6-8, 2023, at the boston marriott copley place in boston, ma, and oppenheimer's 33rd annual healthcare conference, which is taking place virtually, march 13-15, 2023. details are as follows:
SPRO Ratings Summary
SPRO Quant Ranking